A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer
Crossref DOI link: https://doi.org/10.1007/s00280-015-2827-3
Published Online: 2015-08-18
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jones, Robin L.
Bendell, Johanna C.
Smith, David C.
Diefenbach, Konstanze
Lettieri, John
Boix, Oliver
Lockhart, A. Craig
O’Bryant, Cindy
Moore, Kathleen N.
Text and Data Mining valid from 2015-08-18